Kura Oncology Inc (NAS:KURA)
$ 10.39 -0.060 (-0.57%) Market Cap: 922.37 Mil Enterprise Value: 365.82 Mil PE Ratio: 0 PB Ratio: 8.55 GF Score: 28/100

Kura Oncology Inc at TD Cowen Healthcare Conference Transcript

Mar 4, 2026 / 04:50 PM GMT
Release Date Price: $8.55 (+0.59%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

KURA.OQ - Kura Oncology Inc
Kura Oncology Inc at TD Cowen Healthcare Conference
Mar 04, 2026 / 04:50PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Sarah Cowan, it's my pleasure to, moderate a fireside chat with Cura Oncology. We have with us today Troy Wilson, President and CEO, Brian Powell, Chief Commercial Officer, and Molly Leoni, Chief Medical Officer. Tee, maybe I'll toss it to you to begin. Could you give us a brief state of the company overview, biggest strengths, biggest challenges, and what does Kra need to achieve to drive outperformance over the next year?

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Sure, Phil, thanks to you and TD Cowan for the, invitation, the opportunity to participate. This is always
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot